Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...

Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...

demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute intermediate-risk pulmonary ... In an ischemic stroke, an artery in the brain is blocked by ...

Right ventricular–pulmonary artery coupling (RV-PAC) describes the energy transfer within the whole cardiopulmonary unit. Thus, it can identify the earliest signs of decompensation even before ...

The Element sheath allowed easy access to the left pulmonary artery, where thrombectomy was performed in similar fashion. After 20 minutes of device time, clot was removed and reperfusion was achieved ...

View all available purchase options and get full access to this article.

the FDA approved Akura Medical's IDE application to initiate the QUADRA-PE study evaluating the Katana thrombectomy system for acute pulmonary embolism (PE). . On October 1, 2024, Surmodics ...